Ads
related to: lymphoma survival rate- Register for Updates
Stay Informed About The Latest
Clinical Data Updates & More
- Efficacy & Safety Data
Review The Clinical Trial Results
Including Subgroup Analyses
- View Dosing Information
Access The Dosing Schedule
& Administration Info
- Patient Characteristics
See Which Patient Types Are Fit
For This FDA-Approved Treatment
- Register for Updates
Search results
FDA approves Bristol Myers Squibb’s Breyanzi for follicular lymphoma
Pharmaceutical Technology via Yahoo Finance· 13 hours agoThe CD19-directed chimeric antigen receptor (CAR) T cell therapy is...clinical trial evaluating...
FDA Broadens Breyanzi's Follicular Lymphoma Indication
Medscape· 16 hours agoThe overall response rate to the CAR T therapy was 95.7% in phase 2 testing.
Immunotherapy may boost survival after lung cancer surgery
UPI· 5 hours agoImmunotherapy can boost the survival of early-stage lung cancer patients eligible for surgery when...
My doctor told me I had dandruff but the lumps were cancer
Yahoo Life UK· 10 hours agoAt the new hospital, I was put in room 17, which I felt was a good omen as it’s one of my lucky...
Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Zacks via Yahoo Finance· 4 hours agoThis indication is approved under accelerated approval based on response rate and duration of...
BMS Opdivo and Yervoy combo misses primary endpoint in Phase III NSCLC trial
Clinical Trials Arena via Yahoo Finance· 3 days agoBMS did not disclose much detail about the secondary endpoints, such as overall survival (OS),...
What Is Multicentric Castleman Disease?
Healthline· 6 days agoThis rare disease affecting the lymph nodes can increase your risk of developing lymphoma and life threatening infections. Multicentric Castleman disease...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 2 days agoPfizer also recently said its new drug, Adcetris, improved overall survival, progression-free ...
Kite and Arcellx prepare to launch Phase III multiple myeloma trial
Clinical Trials Arena via Yahoo Finance· 7 days agoIn September last year, Kite published Phase II data for Yescarta (axicabtagene ciloleucel) for...
Streamlining Access to Cancer Care Saves Lives
NBC Washington· 4 days agoHealthcare professionals across the country continue to work diligently to advance cancer care and improve survival rates, and much progress has been...
